[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:myeloproliferative-neoplasm-not-otherwise-specified":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":22,"states":23},"Myeloproliferative Neoplasm, Not Otherwise Specified",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06661915","A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)",[11],"Phase 2","RECRUITING","2026-08-26T02:18:11.042248Z","2026-05-05T02:43:28.360451Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT06291987","Ivosidenib and Ruxolitinib in Patients With Advanced Myeloproliferative Neoplasms (MPNs) That Have an IDH1 Gene Mutation",[19],"Phase 1","2026-08-26T02:15:21.365312Z","2026-05-05T02:43:27.513961Z",[],[]]